Filter News
Area of Research
News Topics
- (-) Bioenergy (12)
- (-) Cybersecurity (8)
- (-) Exascale Computing (4)
- (-) Grid (4)
- (-) Isotopes (5)
- 3-D Printing/Advanced Manufacturing (16)
- Advanced Reactors (4)
- Artificial Intelligence (15)
- Big Data (3)
- Biology (7)
- Biomedical (5)
- Biotechnology (3)
- Buildings (3)
- Chemical Sciences (8)
- Clean Water (1)
- Climate Change (12)
- Composites (4)
- Computer Science (23)
- Coronavirus (2)
- Critical Materials (1)
- Decarbonization (8)
- Education (3)
- Energy Storage (8)
- Environment (13)
- Frontier (6)
- Fusion (4)
- High-Performance Computing (13)
- Machine Learning (5)
- Materials (28)
- Materials Science (14)
- Microscopy (6)
- Molten Salt (1)
- Nanotechnology (6)
- National Security (4)
- Net Zero (2)
- Neutron Science (17)
- Nuclear Energy (8)
- Partnerships (18)
- Physics (9)
- Polymers (1)
- Quantum Computing (3)
- Quantum Science (11)
- Renewable Energy (1)
- Security (7)
- Simulation (7)
- Summit (7)
- Sustainable Energy (7)
- Transportation (7)
Media Contacts
![Radiochemical technicians David Denton and Karen Murphy use hot cell manipulators at Oak Ridge National Laboratory during the production of actinium-227. Radiochemical technicians David Denton and Karen Murphy use hot cell manipulators at Oak Ridge National Laboratory during the production of actinium-227.](/sites/default/files/styles/list_page_thumbnail/public/2016-P07827%5B1%5D.jpg?itok=yJbnFQLU)
The Department of Energy’s Oak Ridge National Laboratory is now producing actinium-227 (Ac-227) to meet projected demand for a highly effective cancer drug through a 10-year contract between the U.S. DOE Isotope Program and Bayer.